ArticleBMC musculoskeletal disorders2025
Multidisciplinary consensus on the management of patients with osteopenia and fracture risk in Spain.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Daily Calcium and Vitamin D Supplementation as a Foundational Pillar in Osteoporosis Management: A Narrative Review.Nutrients · 2026Review
- Changes in Oxidative Stress, Inflammatory and Bone Metabolism Biomarkers Following Sulfurous Water Inhalation in Osteopenic Women.International journal of molecular sciences · 2026Article
- Beyond the T-Score: Individualized Fracture Prevention in Osteopenia.Journal of menopausal medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn Spain, over 3.5 million individuals are diagnosed with osteoporosis, while an even greater number are affected by osteopenia, the precursor stage of this severe condition. Unfortunately, osteoporosis and osteopenia frequently remain undetected until a fracture occurs, potentially resulting in permanent damage or even death.
methodsTo improve the management of osteopenia, a multidisciplinary task force was established, consisting of 45 experts, including patients, doctors, nurses, pharmacists, and managers from 20 scientific organisations related to this pathology. With the scientific endorsement of the Spanish Society of Healthcare Quality (SECA) and using the Delphi qualitative research method. Although there was consistent agreement across the 75 variables analysed, a clear and consolidated consensus was reached on 56 of them (75%) after two rounds of consultation.
resultsThis agreement encompassed 13 variables related to general considerations, 10 of the 18 concerning diagnosis (55%), and 33 of the 44 regarding treatment (75%). Consistent agreement was reached on all issues consulted, strong consensus (≥ 80% agreement) was achieved for 50/57 variables (88%). Key recommendations highlight the importance of lifestyle modifications for people with osteopenia, including proper nutrition, fall prevention, regular physical exercise, weight control, smoking cessation, and alcohol consumption control.
conclusionsThe study concludes that the current clinical management focuses excessively on the diagnosis of osteoporosis, neglecting previous stages of low bone mineral density, such as osteopenia, bone quality, and bone tissue structure. There is limited monitoring of risk factors such as previous fractures, despite their severe consequences. Therefore, a set of general recommendations related to diagnosis and treatment is proposed to improve the management of patients with this condition.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.